Literature DB >> 7605661

Monitoring of blood-10B concentration for boron neutron capture therapy using prompt gamma-ray analysis.

C P Raaijmakers1, M W Konijnenberg, L Dewit, D Haritz, R Huiskamp, K Philipp, A Siefert, F Stecher-Rasmussen, B J Mijnheer.   

Abstract

The aim of the present study was to monitor the blood-10B concentration of laboratory dogs receiving boron neutron capture therapy, in order to obtain optimal agreement between prescribed and actual dose. A prompt gamma-ray analysis system was developed for this purpose at the High Flux Reactor in Petten. The technique was compared with inductively coupled plasma-atomic emission spectrometry and showed good agreement. A substantial variation in 10B clearance pattern after administration of borocaptate sodium was found between the different dogs. Consequently, the irradiation commencement was adjusted to the individually determined boron elimination curve. Mean blood-10B concentrations during irradiation of 25.8 +/- 2.2 micrograms/g (1 SD, n = 18) and 49.3 +/- 5.3 micrograms/g (1 SD, n = 17) were obtained for intended concentrations of 25 micrograms/g and 50 micrograms/g, respectively. These variations are a factor of two smaller than irradiations performed at a uniform post-infusion irradiation starting time. Such a careful blood-10B monitoring procedure is a prerequisite for accurately obtaining such steep dose-response curves as observed during the dog study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605661     DOI: 10.3109/02841869509094017

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  1 in total

1.  Organisation and management of the first clinical trial of BNCT in Europe (EORTC protocol 11961).EORTC BNCT study group.

Authors:  W Sauerwein; R Moss; J Rassow; F Stecher-Rasmussen; K Hideghéty; J G Wolbers; H Sack
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.